DK144076A - - Google Patents

Info

Publication number
DK144076A
DK144076A DK144076A DK144076A DK144076A DK 144076 A DK144076 A DK 144076A DK 144076 A DK144076 A DK 144076A DK 144076 A DK144076 A DK 144076A DK 144076 A DK144076 A DK 144076A
Authority
DK
Denmark
Application number
DK144076A
Other languages
Danish (da)
Other versions
DK141171C (it
DK141171B (da
Inventor
Y Kamano
K Michishita
T Seki
I Tanaka
Original Assignee
Taisho Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharm Co Ltd filed Critical Taisho Pharm Co Ltd
Publication of DK144076A publication Critical patent/DK144076A/da
Publication of DK141171B publication Critical patent/DK141171B/da
Application granted granted Critical
Publication of DK141171C publication Critical patent/DK141171C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK144076AA 1975-03-31 1976-03-30 Fremgangsmåde til fremstilling af 17alfa-acyloxy-21-halogenpregnaner. DK141171B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3891475 1975-03-31
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP5208575 1975-05-01
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (3)

Publication Number Publication Date
DK144076A true DK144076A (it) 1976-10-01
DK141171B DK141171B (da) 1980-01-28
DK141171C DK141171C (it) 1980-07-07

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK144076AA DK141171B (da) 1975-03-31 1976-03-30 Fremgangsmåde til fremstilling af 17alfa-acyloxy-21-halogenpregnaner.

Country Status (14)

Country Link
US (1) US4113680A (it)
CA (1) CA1044225A (it)
CH (1) CH609709A5 (it)
DE (1) DE2613875A1 (it)
DK (1) DK141171B (it)
ES (1) ES446411A1 (it)
FR (1) FR2306214A1 (it)
GB (1) GB1508517A (it)
HU (1) HU174850B (it)
IN (1) IN142583B (it)
NL (1) NL7603249A (it)
PT (1) PT64885B (it)
SE (1) SE403380B (it)
YU (1) YU54476A (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (it) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
BRPI0113042B8 (pt) * 2000-08-05 2021-05-25 Glaxo Group Ltd composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
BR0209271A (pt) * 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
IN142583B (it) 1977-07-30
ES446411A1 (es) 1979-02-01
CH609709A5 (it) 1979-03-15
HU174850B (hu) 1980-03-28
GB1508517A (en) 1978-04-26
YU54476A (en) 1982-05-31
CA1044225A (en) 1978-12-12
DK141171C (it) 1980-07-07
DK141171B (da) 1980-01-28
NL7603249A (nl) 1976-10-04
DE2613875A1 (de) 1976-10-14
SE403380B (sv) 1978-08-14
FR2306214A1 (fr) 1976-10-29
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
FR2306214B1 (it) 1981-04-30
PT64885B (en) 1977-11-17
US4113680A (en) 1978-09-12

Similar Documents

Publication Publication Date Title
FR2306214B1 (it)
JPS527260U (it)
JPS5197732A (it)
JPS5613664Y2 (it)
JPS552293Y2 (it)
JPS5151195Y2 (it)
JPS5756051B2 (it)
JPS5290882U (it)
JPS5531074Y2 (it)
JPS5188384U (it)
JPS5261901U (it)
JPS5246200U (it)
JPS5238752U (it)
CH607112A5 (it)
CH603193A5 (it)
CH612297A5 (it)
CH611973A5 (it)
CH611245A5 (it)
CH610493A5 (it)
CH610393A5 (it)
CH591866A5 (it)
CH594132A5 (it)
CH607006A5 (it)
CH606952A5 (it)
CH606924A5 (it)

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed